Contact Us

Defective Drugs
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Ditropan

FDA: Bolster warning on bladder drug

Apr 10, 2007
| AP
Johnson & Johnson's bladder drug Ditropan needs stronger cau tions about the risk of hallucination and similar problems in children and older...

Page 1/1